Journal of Pain and Symptom Management
Volume 36, Issue 1 , Pages 39-45 , July 2008

Pain, Substance Use Disorders and Opioid Analgesic Prescription Patterns in Veterans with Hepatitis C

  • Ashlee J. Whitehead, MA, LPC, CADC

      Affiliations

    • Northwest Hepatitis C Resource Center
    • Behavioral Health & Clinical Neurosciences Division
    • Corresponding Author InformationAddress correspondence to: Ashlee Whitehead, MA, LPC, CADC, Portland VA Medical Center, 3710 Southwest U.S. Veterans Hospital Road, Portland, OR 97207, USA.
    • ,
  • Steven K. Dobscha, MD

      Affiliations

    • Behavioral Health & Clinical Neurosciences Division
    • Columbia Center for the Study of Chronic, Comorbid Mental and Physical Disorders
    • Department of Psychiatry, Oregon Health & Science University, Portland, Oregon
    • ,
  • Benjamin J. Morasco, PhD

      Affiliations

    • Northwest Hepatitis C Resource Center
    • Behavioral Health & Clinical Neurosciences Division
    • Department of Psychiatry, Oregon Health & Science University, Portland, Oregon
    • ,
  • Samantha Ruimy, BS

      Affiliations

    • Northwest Hepatitis C Resource Center
    • Behavioral Health & Clinical Neurosciences Division
    • ,
  • Cara Bussell, BA

      Affiliations

    • Northwest Hepatitis C Resource Center
    • Behavioral Health & Clinical Neurosciences Division
    • ,
  • Peter Hauser, MD

      Affiliations

    • Northwest Hepatitis C Resource Center
    • Behavioral Health & Clinical Neurosciences Division
    • J.E.N.S. Lab, Portland VA Medical Center
    • Department of Psychiatry, Oregon Health & Science University, Portland, Oregon
    • Department of Behavioral Neurosciences, Oregon Health & Science University, Portland, Oregon
    • Department of Internal Medicine, Oregon Health & Science University, Portland, Oregon

,Accepted 15 August 2007.

References 

  1. Dominitz JA, Boyko EJ, Koepsell TD, et al. Elevated prevalence of hepatitis C infection in users of United States Veterans medical centers. Hepatology. 2005;41(1):88–96
  2. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med. 2006;144(10):705–714
  3. Poynard T, Cacoub P, Ratziu V, et al. Fatigue in patients with chronic hepatitis C. J Viral Hepat. 2002;9(4):295–303
  4. Vassilopoulos D, Calabrese LH. Rheumatic manifestations of hepatitis C infection. Curr Rheumatol Rep. 2003;5(3):200–204
  5. Buskila D. Hepatitis C-associated arthritis. Curr Opin Rheumatol. 2000;12(4):295–299
  6. Cacoub P, Poynard T, Ghillani P, et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C. Arthritis Rheum. 1999;42(10):2204–2212
  7. Sterling RK, Bralow S. Extrahepatic manifestations of hepatitis C virus. Curr Gastroenterol Rep. 2006;8(1):53–59
  8. Barkhuizen A, Rosen HR, Wolf S, et al. Musculoskeletal pain and fatigue are associated with chronic hepatitis C: a report of 239 hepatology clinic patients. Am J Gastroenterol. 1999;94(5):1355–1360
  9. Ballantyne JC, Mao J. Opioid therapy for chronic pain. N Engl J Med. 2003;349(20):1943–1953
  10. Caudill-Slosberg MA, Schwartz LM, Woloshin S. Office visits and analgesic prescriptions for musculoskeletal pain in US: 1980 vs. 2000. Pain. 2004;109(3):514–519
  11. Clark JD. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage. 2002;23(2):131–137
  12. McQuay H. Opioids in pain management. Lancet. 1999;353(9171):2229–2232
  13. Bloodworth D. Issues in opioid management. Am J Phys Med Rehabil. 2005;84(3 Suppl):S42–S55
  14. Zdilar D, Franco-Bronson K, Buchler N, Locala JA, Younossi ZM. Hepatitis C, interferon alfa, and depression. Hepatology. 2000;31(6):1207–1211
  15. Loftis JM, Matthews AM, Hauser P. Psychiatric and substance use disorders in individuals with hepatitis C: epidemiology and management. Drugs. 2006;66(2):155–174
  16. Sylvestre DL, Loftis JM, Hauser P, et al. Co-occurring hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care. J Urban Health. 2004;81(4):719–734
  17. Fireman M, Indest DW, Blackwell A, Whitehead AJ, Hauser P. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care. Clin Infect Dis. 2005;15(40 Suppl. 5):S286–S291
  18. Huckans MS, Blackwell AD, Harms TA, Indest DW, Hauser P. Integrated hepatitis C virus treatment: addressing comorbid substance use disorders and HIV infection. AIDS. 2005;19(Suppl. 3):S106–S115
  19. el-Serag HB, Kunik M, Richardson P, Rabeneck L. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002;123(2):476–482
  20. Seeff LB, Hoofnagle JH. National Institutes of Health consensus development conference: management of hepatitis C: 2002. Hepatology. 2002;36(5 Suppl. 1):S1–S2
  21. Schiff ER. Hepatitis C and alcohol. Hepatology. 1997;26(3 Suppl. 1):39S–42S
  22. Cohen MJ, Jasser S, Herron PD, Margolis CG. Ethical perspectives: opioid treatment of chronic pain in the context of addiction. Clin J Pain. 2002;18(4 Suppl):S99–S107
  23. Collins ED, Streltzer J. Should opioid analgesics be used in the management of chronic pain in opiate addicts?. Am J Addict. 2003;12(2):93–100
  24. Gilson AM, Joranson DE. U.S. policies relevant to the prescribing of opioid analgesics for the treatment of pain in patients with addictive disease. Clin J Pain. 2002;18(4 Suppl):S91–S98
  25. Rosenblum A, Joseph H, Fong C, et al. Prevalence and characteristics of chronic pain among chemically dependent patients in methadone maintenance and residential treatment facilities. JAMA. 2003;289(18):2370–2378
  26. Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain. 2002;18(4 Suppl):S28–S38
  27. Riley TR, Bhatti AM. Preventive strategies in chronic liver disease: part I. Alcohol, vaccines, toxic medications and supplements, diet and exercise. Am Fam Physician. 2001;64(9):1555–1560
  28. Li Y, Zhang T, Douglas SD, et al. Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol. 2003;163(3):1167–1175
  29. Kotb HI, el-Kabsh MY, Emara SE, Fouad EA. Pharmacokinetics of controlled release morphine (MST) in patients with liver cirrhosis. Br J Anaesth. 1997;79(6):804–806
  30. Potter M, Schafer S, Gonzalez-Mendez E, et al. Opioids for chronic nonmalignant pain. Attitudes and practices of primary care physicians in the UCSF/Stanford Collaborative Research Network. University of California, San Francisco. J Fam Pract. 2001;50(2):145–151
  31. Kirsh KL, Whitcomb LA, Donaghy K, Passik SD. Abuse and addiction issues in medically ill patients with pain: attempts at clarification of terms and empirical study. Clin J Pain. 2002;18(4 Suppl):S52–S60
  32. Passik SD, Kirsh KL, Donaghy KB, Portenoy RK. Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. Clin J Pain. 2006;22(2):173–181
  33. Portenoy RK. Opioid therapy for chronic nonmalignant pain. Pain Res Manag. 1996;1(1):17–28
  34. Robinson RC, Gatchel RJ, Polatin P, et al. Screening for problematic prescription opioid use. Clin J Pain. 2001;17(3):220–228

PII: S0885-3924(08)00063-8

doi: 10.1016/j.jpainsymman.2007.08.013

Journal of Pain and Symptom Management
Volume 36, Issue 1 , Pages 39-45 , July 2008

Article Tools